GeneScience Pharmaceuticals Co., Ltd.

GeneScience Pharmaceuticals (GenSci) is one of the largest, most profitable and fastest-growing biopharmaceutical companies in China, with 7 marketed products and more than 10 in the pipeline, focused on developing, manufacturing and marketing biologics and innovative biogenerics. Recognized with China's first Medical Center for Quality Controls of Genetic Engineering Pharmaceuticals designation in 2007 and the first state genetic engineering Enterprise's New Drug Incubation Base in 2009, GenSci has sustained rapid growth over the past twenty years, with its Jintropin (recombinant human growth hormone) the leading rhGH brand in China since its 1998 launch.